(Total Views: 811)
Posted On: 09/16/2020 5:15:17 PM
Post# of 153927
Re: Rubraquercus #56237
I did not listen to the call. Apparently, those words were said by NP.
If that is the case, then I am extraordinarily disappointed, particularly in light of the following:
"CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"
, a late-stage biotechnology company announced today it has provided its Top-line Report from its recently completed, randomized, double-blind, Phase 2 trial for COVID-19 patients with mild-to-moderate symptoms to the U.S. Food and Drug Administration (FDA), and requested emergency use approval ."
https://www.cytodyn.com/newsroom/press-releas...ts-phase-2
If that is the case, then I am extraordinarily disappointed, particularly in light of the following:
"CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"
, a late-stage biotechnology company announced today it has provided its Top-line Report from its recently completed, randomized, double-blind, Phase 2 trial for COVID-19 patients with mild-to-moderate symptoms to the U.S. Food and Drug Administration (FDA), and requested emergency use approval ." https://www.cytodyn.com/newsroom/press-releas...ts-phase-2
(3)
(0)
